Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 119.20%167.06M | -53.96%71.06M | 0.94%132.4M | -52.94%50.65M | -64.89%76.21M | -53.67%154.35M | -53.68%131.16M | -34.13%107.64M | 51.17%217.06M | 54.28%333.12M |
| Notes receivable and accounts receivable | 61.61%1.63B | 77.07%1.63B | 37.34%1.33B | 48.96%1.31B | -0.68%1.01B | 16.43%919.63M | 31.97%966.59M | 22.89%882.58M | 30.49%1.02B | 15.81%789.86M |
| -Notes receivable | 130,804.14%44.49M | 140.90%45.13M | 411.04%30.91M | 168.71%27.06M | --33.98K | --18.73M | --6.05M | --10.07M | ---- | ---- |
| -Accounts receivable | 57.21%1.59B | 75.75%1.58B | 34.98%1.3B | 47.58%1.29B | -0.69%1.01B | 14.06%900.89M | 31.15%960.54M | 21.49%872.51M | 30.49%1.02B | 15.81%789.86M |
| Other receivables (including interest and dividends) | 18.72%12.61M | 345.27%14.64M | 164.21%3.95M | 70.67%2.72M | -28.32%10.62M | -71.68%3.29M | -87.97%1.5M | -68.47%1.59M | 768.12%14.82M | 505.50%11.61M |
| -Other receivable | ---- | 345.27%14.64M | ---- | ---- | ---- | -71.68%3.29M | ---- | -68.47%1.59M | ---- | 505.50%11.61M |
| Advance payment | 17.10%259.06M | 87.66%210.2M | 90.75%227.01M | 51.24%116.06M | 64.00%221.23M | -2.83%112.01M | -22.67%119.01M | -5.93%76.73M | -2.62%134.9M | 10.88%115.27M |
| Inventories | 10.08%606.11M | 2.67%582.47M | 21.71%586.22M | 33.03%659.2M | 4.83%550.6M | 11.76%567.32M | -22.66%481.67M | -16.62%495.54M | -4.61%525.25M | -16.40%507.64M |
| Receivable financing | 44.79%241.24M | -24.36%185.37M | -4.49%242.96M | -61.13%106.93M | 132.72%166.62M | 15.10%245.06M | 254.86%254.37M | 3.76%275.12M | -75.81%71.59M | -6.18%212.91M |
| Non-current assets due within one year | 894.28%11.44M | 894.79%11.44M | 895.25%11.44M | 933.03%11.74M | -7.37%1.15M | 149.89%1.15M | 324.74%1.15M | 319.77%1.14M | --1.24M | --460.3K |
| Other current assets | 46.75%33.91M | 82.46%36.94M | -18.45%24.22M | 44.73%54.23M | 80.99%23.11M | 5.57%20.25M | -29.68%29.7M | -17.14%37.47M | -36.45%12.77M | -42.67%19.18M |
| Total current assets | 43.90%2.96B | 35.47%2.74B | 28.74%2.56B | 23.35%2.32B | 3.26%2.06B | 1.66%2.02B | 3.45%1.99B | 0.13%1.88B | 3.35%1.99B | 6.34%1.99B |
| Non Current assets | ||||||||||
| Investment real estate | 10.30%99.41M | 11.69%100.77M | 11.75%102.14M | 11.73%103.42M | -2.55%90.12M | -3.64%90.23M | -5.19%91.4M | -5.16%92.57M | -8.79%92.48M | 45.39%93.63M |
| Long term receivable account | -45.23%1.06M | -39.17%1.31M | -36.27%1.5M | -40.12%1.72M | -34.90%1.93M | -45.22%2.15M | -52.39%2.36M | 395.72%2.87M | --2.97M | --3.92M |
| Fixed assets | ---- | 11.99%1.18B | ---- | ---- | ---- | 6.15%1.05B | ---- | -0.73%1.01B | ---- | 8.96%990.45M |
| Constru in process | ---- | -15.49%198.14M | ---- | ---- | ---- | 37.69%234.47M | ---- | 6.10%183.71M | ---- | -35.57%170.29M |
| Intangible assets | 25.73%87.28M | -11.80%60.05M | -11.78%60.56M | -11.76%61.08M | -0.88%69.42M | -3.57%68.08M | -6.53%68.65M | -6.51%69.22M | 5.06%70.03M | 37.16%70.6M |
| Long deferred expense | 2.32%93.12M | 2.98%90.5M | -11.19%82.52M | 2.17%86.65M | 6.04%91.01M | 1.50%87.88M | 11.25%92.91M | 6.72%84.81M | 19.72%85.83M | 35.60%86.58M |
| Deferred tax assets | 52.52%67.43M | 86.04%65.01M | 71.55%58.36M | 69.94%53.67M | 65.21%44.21M | 25.01%34.95M | 19.16%34.02M | 59.15%31.58M | 39.76%26.76M | 31.64%27.95M |
| Usufruct assets | 16.41%5.66M | -19.30%4.07M | 750.51%4.33M | 442.75%4.6M | 344.40%4.86M | 261.75%5.04M | -69.90%509.19K | -54.75%846.77K | -49.08%1.09M | -42.56%1.39M |
| Other non current assets | 125.39%19.45M | -4.26%13.28M | -61.92%6.36M | -73.32%7.19M | -52.52%8.63M | -13.49%13.87M | -26.41%16.7M | 38.52%26.93M | 10.80%18.18M | -13.56%16.04M |
| Total non current assets | 8.63%1.75B | 7.72%1.71B | 7.64%1.67B | 12.19%1.68B | 9.80%1.61B | 8.71%1.59B | 5.20%1.56B | 1.30%1.5B | 2.21%1.46B | 4.70%1.46B |
| Total assets | 28.44%4.71B | 23.26%4.45B | 19.47%4.23B | 18.40%4B | 6.02%3.67B | 4.64%3.61B | 4.21%3.54B | 0.65%3.38B | 2.87%3.46B | 5.64%3.45B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 98.07%1.2B | 113.96%1.24B | 46.15%960.48M | 65.90%801.76M | 15.44%606.46M | -19.67%578.32M | -24.21%657.17M | -42.94%483.28M | -46.41%525.36M | -18.25%719.9M |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | -88.63%379.95K | -82.29%453.56K | 4,488.59%125.19K | --901.39K | -77.97%3.34M |
| Notes payable and accounts payable | 40.70%306.26M | 57.69%331.34M | 70.79%321.5M | 53.81%332.95M | 7.26%217.67M | -0.37%210.12M | -33.12%188.24M | -1.02%216.47M | 5.01%202.93M | 17.79%210.89M |
| -Notes payable | --9.75M | ---- | ---- | ---- | ---- | ---- | -66.74%22.19M | -11.27%26.05M | 27.77%27.47M | 52.36%30.06M |
| -Accounts payable | 36.22%296.51M | 57.69%331.34M | 93.61%321.5M | 74.85%332.95M | 24.06%217.67M | 16.19%210.12M | -22.68%166.05M | 0.57%190.42M | 2.16%175.46M | 13.51%180.83M |
| Contract liabilities | 86.27%692.31K | 23.11%692.31K | -95.88%710.42K | -95.66%737.34K | -99.18%371.66K | -99.00%562.35K | -59.92%17.24M | -61.79%16.98M | 23,116.88%45.53M | 20,753.03%56.25M |
| Salaries payable | 14.33%33.67M | 10.90%27.65M | 7.39%22.58M | 0.24%34.46M | 0.75%29.45M | 23.45%24.94M | -36.02%21.03M | -33.49%34.38M | -34.77%29.23M | -39.40%20.2M |
| Taxs payable | 46.58%32.78M | 70.43%26.26M | -36.69%19.59M | -4.32%17.71M | -38.91%22.36M | -41.18%15.41M | 14.42%30.94M | -42.85%18.51M | 35.76%36.61M | -50.92%26.19M |
| Other payable (including interest and dividends) | 402.56%1.6M | -62.65%1.29M | 102.36%1.19M | -9.37%1.1M | -31.59%318.93K | 652.22%3.46M | 99.00%586.8K | -45.80%1.21M | -65.76%466.23K | -78.47%460.14K |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | --3.02M | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 193.78%1.29M | ---- | ---- | ---- | -4.36%440.06K | ---- | -45.80%1.21M | ---- | -78.47%460.14K |
| Non current liabilities due within one year | 44.82%276.36M | 42.10%190.54M | 526.32%186.97M | 588.85%187.12M | 604.81%190.84M | 474.01%134.09M | 2,509.44%29.85M | 2,230.86%27.16M | 2,982.94%27.08M | 2,590.91%23.36M |
| Other current liabilities | 7,766.05%1.96M | 2,360.20%980.81K | 34.47%3.01M | 30.41%2.88M | -99.58%24.87K | -99.37%39.87K | -59.93%2.24M | -61.74%2.21M | --5.9M | --6.33M |
| Total current liabilities | 73.73%1.85B | 87.75%1.82B | 59.96%1.52B | 72.27%1.38B | 22.14%1.07B | -9.34%967.32M | -24.86%947.76M | -33.49%800.33M | -29.96%874M | -8.40%1.07B |
| Current liabilities | ||||||||||
| Long term loan | 25.61%513.86M | -26.01%337.55M | 5.26%454.08M | 6.46%428.7M | -1.09%409.09M | 90.40%456.21M | --431.38M | --402.69M | --413.6M | --239.6M |
| Estimate liabilities | ---- | ---- | ---- | ---- | -98.13%25.07K | -86.77%333.63K | -31.31%1.25M | -97.48%24.89K | -68.30%1.34M | -14.26%2.52M |
| Deferred tax liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.28K | ---- | ---- |
| Long term deferred income | 93.38%161.88M | 79.72%145.65M | 73.11%120.15M | 18.18%85.71M | 18.83%83.71M | 13.72%81.04M | -5.14%69.4M | -4.86%72.53M | 3.69%70.45M | 0.67%71.27M |
| Lease liabilities | 16.43%4.55M | -24.56%3.14M | 2,365.16%3.4M | 2,396.96%3.66M | 814.23%3.91M | 469.39%4.16M | -83.16%137.93K | -80.21%146.47K | -61.24%427.84K | -55.07%731.14K |
| Total non current liabilities | 36.95%680.29M | -10.23%486.34M | 15.03%577.63M | 8.98%518.07M | 2.25%496.74M | 72.47%541.74M | 562.52%502.17M | 509.76%475.39M | 563.08%485.81M | 316.82%314.12M |
| Total liabilities | 62.05%2.53B | 52.58%2.3B | 44.40%2.09B | 48.68%1.9B | 15.03%1.56B | 9.27%1.51B | 8.44%1.45B | -0.43%1.28B | 2.93%1.36B | 11.36%1.38B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%329.94M | 0.00%329.94M | 0.00%329.94M | 0.00%329.94M | 0.00%329.94M | 0.00%329.94M | 30.00%329.94M | 30.00%329.94M | 30.00%329.94M | 30.00%329.94M |
| Capital reserve funds | -0.50%822.28M | -1.12%817.13M | -1.75%811.98M | 0.00%826.42M | 0.00%826.42M | 0.00%826.42M | -8.44%826.42M | -8.44%826.42M | -8.44%826.42M | -8.44%826.42M |
| Surplus reserve funds | 0.00%31.68M | 0.00%31.68M | 0.00%31.68M | 0.00%31.68M | 0.00%31.68M | 0.00%31.68M | 0.00%31.68M | 0.00%31.68M | 1.32%31.68M | 1.32%31.68M |
| Retained profit | 4.25%953.5M | 2.39%935.94M | 3.94%930.69M | 3.50%916.17M | 3.64%914.61M | 6.68%914.14M | 5.46%895.39M | 2.43%885.17M | 5.96%882.49M | 4.45%856.92M |
| Less:Treasury stock | -91.70%2.73M | -90.91%2.73M | -86.37%2.73M | --37.2M | --32.85M | --30.01M | --20.01M | ---- | ---- | ---- |
| Specific reserves | 19.05%38.41M | 23.39%36.88M | 27.47%34.79M | 22.86%33.43M | 16.77%32.27M | 20.08%29.89M | 16.58%27.29M | 29.92%27.21M | 38.10%27.63M | 34.54%24.89M |
| Shareholders equity without minority interests | 3.38%2.17B | 2.23%2.15B | 2.18%2.14B | 0.00%2.1B | 0.19%2.1B | 1.56%2.1B | 1.47%2.09B | 1.32%2.1B | 2.83%2.1B | 2.14%2.07B |
| Minority interests | --1.2M | ---134.85K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total shareholder equity | 3.44%2.17B | 2.22%2.15B | 2.18%2.14B | 0.00%2.1B | 0.19%2.1B | 1.56%2.1B | 1.47%2.09B | 1.32%2.1B | 2.83%2.1B | 2.14%2.07B |
| Total liabilityies and equity | 28.44%4.71B | 23.26%4.45B | 19.47%4.23B | 18.40%4B | 6.02%3.67B | 4.64%3.61B | 4.21%3.54B | 0.65%3.38B | 2.87%3.46B | 5.64%3.45B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.